Status:
COMPLETED
Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
Lead Sponsor:
Stiftung Institut fuer Herzinfarktforschung
Collaborating Sponsors:
Novartis Pharmaceuticals
Conditions:
Arterial Hypertension
Eligibility:
All Genders
Brief Summary
In Germany nearly half of the population present elevated values of blood pressure, with - as a result of lifestyle factors and a growing average age - further increasing numbers. Consequences of art...
Eligibility Criteria
Inclusion
- treatment as outpatient
- arterial hypertension
- treatment with a renin inhibitor, ACE inhibitor, ARB, or without RAS blockade
- informed consent
Exclusion
- foreseeable difficulties to perform follow up
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
15337 Patients enrolled
Trial Details
Trial ID
NCT01454583
Start Date
October 1 2008
End Date
July 1 2012
Last Update
July 21 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.